The flow injection-immunoassay has been used for the determination of trace bioactive materials with high specificity and simplicity.1'2 The principle of this method is almost the same as that of solid phase immunoassay, which is based on a competitive reaction between antigen (the target compound) and labeled antigen with immobilized antibody. The antigen bound on immobilized antibody thus must be purged out prior to the subsequent analysis. The continuous flow analysis using immobilized antigen to remove unbound labeled antibody after the competitive reaction with antigen has also been developed, but a highly purified monospecific antibody such as monoclonal antibody is required to minimize the background level. 3, 4 If we employ a reactor consisting of labeled antibody bound on immobilized antigen, the analyte bound with labeled antibody in an eluent from the reactor can be determined successively (Fig. 1) . Moreover, in this method, polyclonal antibody is applicable without any prior purification. The present paper deals with the development of a novel rapid and convenient method named flow injection-immunometric assay (FIIMA). HCI, the activated ester obtained was immobilized on aminoalkyl porous glass beads (2 g) in dioxan/pyridine (1:1, 6 ml).
Preparation of fluorescein-labeled Fab fragments (FI--Fab)
The antiserum was obtained from a rabbit against 2-bovine serum albumin conjugate in the usual manner.6 The immunoglobulin G (IgG) fraction was prepared by the method of Horejsi and Smetana' and the IgG was then subjected to the selective proteolysis to form Fab fragments by the method of Porters with minor modifications. The Fab fragments thus obtained were subjected to condensation reaction with FITC (1.3 equivalent mole), followed by column chromatography on DEAE-Sephadex A-50 with linear gradient elution from 150 mM to 1 M NaCI in 10 mM sodium phosphate buffer (pH 7.3) and then on Sephadex G-25 to give FlFab according to the method of Cebra and Goldstein.9
The system for FIIMA
The apparatus used was a Model M-45 solvent delivery system (Millipore-Waters, Milford, MA, USA) equipped with a Model 650-1OLC fluorescence spectrophotometer (Hitachi, Tokyo, Japan).
Results and Discussion
The initial attempt was focused on preparation of FlFab using polyclonal antibody raised against 7a-carboxymethylthio-17a-OHP-BSA conjugate in a rabbit. Since use of a monovalent affinity component is preferable for obtaining a facile response, Fab fragments were prepared from the IgG fraction of antiserum by treatment with mercuripapain.s The Fab fragments were then labeled with FITC, followed by purification with successive column chromatography on DEAESephadex A-50 and Sephadex G-25. The immunoreactivity to 17a-OHP in the eluent from the column was checked by enzyme immunoassay (EIA) with the second antibody method. The enzyme-labeled antigen used was prepared from /3-galactosidase with N-succinimidyl ester of 2 in the usual manner. 10 The immunoreactive Fl-Fab which reduced the enzyme activity in the immune precipitate was collected.
Next, effort was directed to the synthesis of 17a-OHP immobilized on glass beads. The hapten 2 was coupled with aminoalkyl porous glass via its activated ester. The amount of hapten molecules bound on glass beads was determined spectrophotometrically (at 422 nm) to be 64 nmol/mg employing color reaction with 83%(v/v) H2SOa.11 The glass beads thus obtained was then added by portions into the solution of Fl-Fab at 37° C until the fluorescence intensity (excitation at 495 nm, emission at 522 nm) in the supernatant was no longer decreased. As shown in Fig. 2 , most of the reactive F1-Fab in solution was adsorbed on 60 mg of beads. Through this process, Fl-Fab having an affinity to 17a-OHP was selected from those having different specificities. The reactor consisted of F1-Fab bound with immobilized antigen was packed in a stainless-steel column (10 mmX4.6 mm i.d.) which in turn was connected to the apparatus and equilibrated with 10 mM sodium phosphate buffer (pH 7.3) at 40° C. The eluent was monitored by a fluorescence detector (excitation 480 nm; emission 525 nm). Following injection of 17a-OHP to the reactor, a peak which corresponded to Fl-Fab bound with 17a-OHP was observed within a quarter minute at a flow rate of 0.5 ml/min. The peak height increased linearly according to the amount of 17a-OHP injected in the range of 10 to 300 ng, as depicted in Fig. 3 . The reproducibility of the peak height was determined to be satisfactory by the results of sequential injections of 17a-OHP at 50,100 and 200 ng.
The novel FIIMA is useful for the determination of biological interests including drugs and may be valuable in the clinical field. For the requirement of the determination of the low level of biological importances, the improvement of sensitivity is now in progress in these laboratories.
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